Phreesia (PHR) traded down -0.71 % during a 24 hours period ending at 02:21 PM Central Europe on Tuesday 27th. One Phreesia stock can currently be bought for about USD 12.61 on popular exchanges. Current supply of Phreesia stocks is 61.7 mn. Phreesia has a current market capitalization of USD 787.1 mn and approximately USD 7.2 mn worth of Phreesia was traded on exchanges in the last 24 hours. Since last month end, Phreesia has traded 24.85 % up. Simple moving average of last 200 days is at USD 11.01. The highest price of past 52 weeks was recorded at USD 23.86 on 10/29/2025. 52 weeks low was at USD 7.77 on 03/31/2026.

Summary of the latest news for Phreesia

Phreesia, Inc. filed a Form 4 on October 26, 2026, reporting that its President of Network Solutions, a non‑director officer, executed two purchases of the company’s common stock on October 22. Each transaction involved the acquisition of a small block of shares at prices above the market level, reflecting a modest increase in the officer’s holdings. The filings confirm that the officer remains an indirect owner, with the shares held through a spouse, and that the total position after the transactions is approximately 22,000 shares. The disclosure was made in accordance with SEC regulations and provides a clear record of the officer’s recent share ownership changes.

Here is how related stocks have performed in the past 24 hours:

  • Critical Metals (CRML) traded up 0.31 % and now trades at USD 6.38. Current market capitalisation for Critical Metals is USD 934.9 mn.

  • Integra Lifesciences (IART) traded up 1.6 % and now trades at USD 12.1. Integra Lifesciences has a market capitalisation of USD 939.8 mn. Current price/earnings ratio for Integra Lifesciences is 73.5.

  • Jade Biosciences (JBIO) traded down -0.62 % and now trades at USD 14.5. Jade Biosciences has a market capitalisation of USD 944.4 mn.

  • Odyssey Therapeutics (ODTX) traded down -1.53 % and now trades at USD 19.3. Current market capitalisation for Odyssey Therapeutics is USD 939.2 mn.

  • Quidelortho (QDEL) traded up 0.29 % and now trades at USD 13.77. Current market capitalisation for Quidelortho is USD 944.3 mn.

About Phreesia

Phreesia Inc. is a health care software development company based in New York, United States. The company specializes in providing solutions for appointment scheduling, registration, clinical support, patient surveys, and analysis and report generation. Phreesia aims to serve patients and doctors nationwide in the US. You can find more information about their offerings and initiatives on their website at www.phreesia.com . They are listed on the New York Stock Exchange.